• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿痰液诱导的安全性及应用

Safety and use of sputum induction in children with cystic fibrosis.

作者信息

Suri Ranjan, Marshall Lindsay J, Wallis Colin, Metcalfe Christopher, Shute Janis K, Bush Andrew

机构信息

Department of Respiratory Paediatrics, Royal Brompton Hospital, London, UK.

出版信息

Pediatr Pulmonol. 2003 Apr;35(4):309-13. doi: 10.1002/ppul.10226.

DOI:10.1002/ppul.10226
PMID:12629630
Abstract

We assessed the safety and use of induced sputum (IS) in children with cystic fibrosis (CF). Forty-eight children (19 males) with CF, mean age 12.6 (range, 7.3-17.0) years and median forced expired volume in 1 sec (FEV(1)) 48% (range, 14-77%) predicted were recruited. Patients spontaneously expectorated sputum and then performed sputum induction by inhalation of nebulized 7% hypertonic saline. Samples were sent for bacteriological culture, and for measurement of the following inflammatory mediators: interleukin-8, myeloperoxidase, eosinophil cationic protein, and neutrophil elastase activity. FEV(1) was performed before and after inhalation of hypertonic saline. There was no increase in mediator levels in IS compared to expectorated sputum (ES) samples. Only 3 patients demonstrated significant bronchoconstriction following inhalation of hypertonic saline, by the method used. From the ES samples, Pseudomonas aeruginosa was isolated in 13 patients, Staphylococcus aureus in 7 patients, Stenotrophomonas maltophilia in 1 patient, and both Pseudomonas aeruginosa and Staphylococcus aureus in 5 patients. All these organisms were found in the IS samples. However, in 2 patients whose ES grew no organisms, one patient's IS grew Pseudomonas aeruginosa, and the other patient's IS grew Staphylococcus aureus. In our study, sputum induction was safe, with no proinflammatory effect.

摘要

我们评估了诱导痰(IS)在囊性纤维化(CF)患儿中的安全性及应用情况。招募了48例CF患儿(19例男性),平均年龄12.6岁(范围7.3 - 17.0岁),1秒用力呼气容积(FEV₁)中位数为预计值的48%(范围14% - 77%)。患者先自行咳出痰液,然后通过吸入雾化的7%高渗盐水进行痰液诱导。样本被送去进行细菌学培养,并检测以下炎症介质:白细胞介素 - 8、髓过氧化物酶、嗜酸性粒细胞阳离子蛋白和中性粒细胞弹性蛋白酶活性。在吸入高渗盐水前后测量FEV₁。与咳出的痰液(ES)样本相比,IS中的介质水平没有升高。采用该方法,只有3例患者在吸入高渗盐水后出现明显支气管收缩。从ES样本中,13例患者分离出铜绿假单胞菌,7例患者分离出金黄色葡萄球菌,1例患者分离出嗜麦芽窄食单胞菌,5例患者同时分离出铜绿假单胞菌和金黄色葡萄球菌。所有这些微生物都在IS样本中被发现。然而,在2例ES未培养出微生物的患者中,1例患者的IS培养出铜绿假单胞菌,另1例患者的IS培养出金黄色葡萄球菌。在我们的研究中,痰液诱导是安全的,没有促炎作用。

相似文献

1
Safety and use of sputum induction in children with cystic fibrosis.囊性纤维化患儿痰液诱导的安全性及应用
Pediatr Pulmonol. 2003 Apr;35(4):309-13. doi: 10.1002/ppul.10226.
2
Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.囊性纤维化患儿吸入高渗盐水后获取痰液和咳嗽拭子样本的临床价值。
Pediatr Pulmonol. 2004 Jul;38(1):82-7. doi: 10.1002/ppul.20035.
3
Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.诱导痰炎症指标与囊性纤维化患儿的肺功能相关。
J Pediatr. 2002 Dec;141(6):811-7. doi: 10.1067/mpd.2002.129847.
4
Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic.儿科囊性纤维化诊所中咳出痰液收集的实际情况。
Arch Pediatr Adolesc Med. 2007 Jun;161(6):603-6. doi: 10.1001/archpedi.161.6.603.
5
Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.超声雾化高渗盐水治疗囊性纤维化的短期疗效
Pediatr Pulmonol. 1996 Feb;21(2):77-83. doi: 10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M.
6
Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.在囊性纤维化患者的呼气冷凝物中,无法通过聚合酶链反应检测到铜绿假单胞菌和洋葱伯克霍尔德菌。
Pediatr Pulmonol. 2003 Oct;36(4):348-52. doi: 10.1002/ppul.10352.
7
Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.重组人脱氧核糖核酸酶和高渗盐水对囊性纤维化患儿气道炎症的影响。
Am J Respir Crit Care Med. 2002 Aug 1;166(3):352-5. doi: 10.1164/rccm.2110015.
8
Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.囊性纤维化患儿诱导痰中炎症和感染标志物的变异性
J Pediatr. 2004 Nov;145(5):689-92. doi: 10.1016/j.jpeds.2004.06.054.
9
Predictors of mortality in adults with cystic fibrosis.成年囊性纤维化患者的死亡预测因素。
Pediatr Pulmonol. 2007 Jun;42(6):525-32. doi: 10.1002/ppul.20619.
10
Association between pulmonary function and sputum biomarkers in cystic fibrosis.囊性纤维化患者肺功能与痰液生物标志物之间的关联
Am J Respir Crit Care Med. 2007 Apr 15;175(8):822-8. doi: 10.1164/rccm.200609-1354OC. Epub 2007 Jan 18.

引用本文的文献

1
Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective.儿童呼吸道疾病吸入性黏液活性药物专家小组建议:印度视角
Front Pediatr. 2023 Dec 4;11:1322360. doi: 10.3389/fped.2023.1322360. eCollection 2023.
2
Diagnosis and Management of Cystic Fibrosis Exacerbations.囊性纤维化加重的诊断和管理。
Semin Respir Crit Care Med. 2023 Apr;44(2):225-241. doi: 10.1055/s-0042-1760250. Epub 2023 Feb 6.
3
Acute Pulmonary Exacerbations in Cystic Fibrosis.囊性纤维化的急性肺部恶化。
Semin Respir Crit Care Med. 2019 Dec;40(6):792-803. doi: 10.1055/s-0039-1697975. Epub 2019 Oct 28.
4
Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.高渗盐水在囊性纤维化患者痰液诱导和病原体检测中的应用
Lung. 2017 Aug;195(4):431-439. doi: 10.1007/s00408-017-0008-3. Epub 2017 Apr 28.
5
Microbial yield from physiotherapy assisted sputum production in respiratory outpatients.呼吸科门诊患者物理治疗辅助咳痰的微生物产量
BMC Pulm Med. 2016 Feb 2;16:23. doi: 10.1186/s12890-016-0188-2.
6
Sputum induction improves detection of pathogens in children with cystic fibrosis.痰液诱导可提高囊性纤维化患儿病原体的检测率。
Pediatr Pulmonol. 2015 Jul;50(7):638-46. doi: 10.1002/ppul.23150. Epub 2015 Jan 7.
7
Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.急性吸入高渗盐水并不能改善所有囊性纤维化患儿的黏液清除功能。
BMC Pulm Med. 2011 Sep 6;11:45. doi: 10.1186/1471-2466-11-45.
8
Sputum biomarkers of inflammation in cystic fibrosis lung disease.囊性纤维化肺病中炎症的痰液生物标志物
Proc Am Thorac Soc. 2007 Aug 1;4(4):406-17. doi: 10.1513/pats.200703-044BR.
9
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.囊性纤维化的病情加重。1:流行病学与发病机制。
Thorax. 2007 Apr;62(4):360-7. doi: 10.1136/thx.2006.060889.